BIOMARK DIAGNOSTICS

BioMark is an oncology-focused company with advanced near-to- market diagnostic technologies designed to improve patient outcomes. They have developed and own multiple intellectual properties (IPs) in detection and quantitation of metabolites. They hand-picked a proven, global enterprise team of scientists, engineers and medical professionals to help commercialize their innovative technology and to increase prediction and accuracy in the diagnosis of cancers by following and incorporating the highest regulatory ,clinical and scientific standards.. Their cross pollinated, balanced and committed team was established in 2007. Their mission is to develop and commercialize innovative technologies to increase prediction and accuracy in diagnosis of cancers.